An interventional study of Blood sample + questionnaire in Breast Cancer Female and Postoperative Pain, sponsored by Université Catholique de Louvain. Recruiting at 1 site in Belgium. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-04-02.
Sponsored by Université Catholique de Louvain · Not applicable, Interventional, and Screening
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 72 studies in Pain, Postoperative with a site in Belgium — 12 open to participants now, 15 under way, none of them phase 3. Pain, Postoperative · Belgium.
Among the 72 studies in Pain, Postoperative with a site in Belgium, this one is the 7th largest by planned enrollment of the 55 interventional ones that give a count, is one of 5 that started in 2025, is one of 34 with no phase, reaches primary completion later than 6 of the 14 other live ones, and was the 61st registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →12 of the 72 studies in Pain, Postoperative with a site in Belgium are open now. Recruiting first, the newest first:
University Ghent · Sites in Belgium
Ages 18+
Universitaire Ziekenhuizen KU Leuven · Sites in Belgium
Ages 18+
University Hospital, Antwerp · Sites in Belgium
Ages 18+
University of Liege · Sites in Belgium
Ages 18+
University Hospital, Ghent · Sites in Belgium
Ages 18+
A study can be open while its sites in Belgium have not opened yet or have stopped. Only those recruiting at a site in Belgium →
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 18 Years and older · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
72 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 5 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 300 is above the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.
Median enrollment 70 across the 55 interventional studies, 250 across the 17 observational. Of the 39 that completed or were terminated, 5 (13%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 72 have an industry lead sponsor. The 10 most frequent:
Université Catholique de Louvain is the lead sponsor of 155 studies on the registry; 60 are open to participants now.
Université Catholique de Louvain has 4 studies filed under Pain, Postoperative — fewer than ten, so there is no comparison to draw.
5 of the studies in Pain, Postoperative with a site in Belgium that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06907810Université Catholique de LouvainStudy of Lipid Mediators in Chronic Postoperative Pain - LICP | 2027-03-31 |
| NCT07941076ChirecPostoperative Pain Management During the First Week After a Forefoot Surgery | 2027-04 |
| NCT07913308Universitair Ziekenhuis BrusselComparison of IV Dexmedetomidine Versus Clonidine Versus no Alpha 2 Agonist on Emergency Delirium, PACU Length of Stay and Time to Hospital Discharge in Children Undergoing (Adeno)Tonsillectomy: a Prospective Observational Study | 2027-05-31 |
| NCT07158684University Hospital, AntwerpSurgical COrncerns and Psychological Evaluation of Patients Undergoing Elective Surgery | 2027-07-01 |
| NCT07640646Universitaire Ziekenhuizen KU LeuvenCardiac Surgery, the Incidence and Impact of Chronic postOperative Pain: a Survey | 2027-08-31 |
Add all 5 to your calendar (.ics) → With an account.
Among the 72 studies in Pain, Postoperative with a site in Belgium, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This interventional prospective study aims firstly to investigate variations in lipid levels in blood samples and their potential relationship with the duration and/or intensity of post-operative pain. Secondly, it aims to investigate the activation of peripheral blood mononuclear cells and neutrophils in patient blood samples. The study will enrol women aged 18 years or older who have been newly diagnosed with primary invasive or non-invasive breast cancer requiring surgical removal of the tumour, with or without axillary surgery.
The main objectives of the study are To assess whether there is an association between circulating levels of lipid mediators and chronicity (> 3 months) of postoperative pain after breast cancer surgery.
To assess whether circulating levels of lipid mediators can predict chronicity of postoperative pain in breast cancer surgery.
To assess the existence of an association between resected tissue levels of lipid mediators and chronicity of postoperative pain in breast cancer surgery.
To assess whether tissue levels of lipid mediators can predict chronicity of postoperative pain in breast cancer surgery.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Metastases
Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Other: Blood sample + questionnaire
Other: Blood sample + questionnaire
* blood sample before tumor surgery and at every follow-up visit * questionnaire before tumor surgery and at every follow-up visit
Pain intensity
Pain intensity will be evaluated using a standardized questionnaire completed by participants at each medical consultation.
Time frame: Throughout the study, an average of 2 years
Pain duration
Pain duration will be evaluated using a standardized questionnaire completed by participants at each medical consultation.
Time frame: Throughout the study, an average of 2 years
Lipid Mediator Levels in Blood
Lipid mediator levels will be quantified in blood samples by LC-MS methods
Time frame: Throughout the study, an average of 2 years
Plan to share: No
No publications or documents are linked to this record.
Started Mar 2025 (actual). Primary completion is estimated for Mar 2027, 24 months after the start.
Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 24 months is above that.
Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Université Catholique de Louvain →